Literature DB >> 19413455

Retinoids: new use by innovative drug-delivery systems.

E Trapasso1, D Cosco, C Celia, M Fresta, D Paolino.   

Abstract

BACKGROUND: Retinoids represent an old class of bioactives used in the treatment of different skin pathologies (such as acne and psoriasis) and in the treatment of many tumors. Unfortunately, they present several side effects, i.e., burning of skin and general malaise after systemic administration and they are very unstable after exposition to light.
METHODS: One of the most promising new approaches for reducing the side effects of retinoids while improving their pharmacological effect is the use of drug-delivery devices. This review explains the current status of retinoid drug transport, which has been developing over the last few years, explaining the modification of their biopharmaceutical properties in detail after encapsulation/inclusion in vesicular and polymeric systems. RESULTS/
CONCLUSION: Different colloidal and micellar systems containing retinoid drugs have been realized furnishing important potential advancements in traditional therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19413455     DOI: 10.1517/17425240902832827

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  3 in total

1.  Microencapsulation of amorphous solid dispersions of fenretinide enhances drug solubility and release from PLGA in vitro and in vivo.

Authors:  Kari Nieto; Susan R Mallery; Steven P Schwendeman
Journal:  Int J Pharm       Date:  2020-06-07       Impact factor: 5.875

Review 2.  Nanocarriers for vascular delivery of antioxidants.

Authors:  Elizabeth Hood; Eric Simone; Paritosh Wattamwar; Thomas Dziubla; Vladimir Muzykantov
Journal:  Nanomedicine (Lond)       Date:  2011-09       Impact factor: 5.307

3.  Nitrite and nitrate-dependent generation of anti-inflammatory fatty acid nitroalkenes.

Authors:  Meghan Delmastro-Greenwood; Kara S Hughan; Dario A Vitturi; Sonia R Salvatore; George Grimes; Gopal Potti; Sruti Shiva; Francisco J Schopfer; Mark T Gladwin; Bruce A Freeman; Stacy Gelhaus Wendell
Journal:  Free Radic Biol Med       Date:  2015-09-16       Impact factor: 7.376

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.